View Older Stories View More Recent Stories

Feb 12, 2026 09:09AM Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:08AM Form SCHEDULE 13G/A EyePoint, Inc. Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:08AM Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:07AM Form SCHEDULE 13G Crane Harbor Acquisition Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:07AM Form SCHEDULE 13G/A MONRO, INC. Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:07AM Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:06AM Form SCHEDULE 13G NABORS INDUSTRIES LTD Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:05AM Form SCHEDULE 13G Launchpad Cadenza Acquis Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:05AM Form SCHEDULE 13G Metropolitan Bank Holdin Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:04AM Form SCHEDULE 13G Leapfrog Acquisition Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:04AM Form SCHEDULE 13G/A Karyopharm Therapeutics Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:04AM Form SCHEDULE 13G Viking Acquisition Corp Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:03AM Form SCHEDULE 13G Karbon Capital Partners Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:03AM Form SCHEDULE 13G Evolution Global Acquisi Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:03AM Form SCHEDULE 13G Minerva Neurosciences, Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:03AM Form SCHEDULE 13G Tailwind 2.0 Acquisition Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:03AM Form SCHEDULE 13G Hall Chadwick Acquisitio Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:03AM Form SCHEDULE 13G Insight Digital Partners Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:02AM Form SCHEDULE 13G Dynamix Corp III Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:02AM Form SCHEDULE 13G Pasithea Therapeutics Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:02AM Form SCHEDULE 13G American Drive Acquisiti Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:02AM Form SCHEDULE 13G Bain Capital GSS Investm Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:02AM Form SCHEDULE 13G General Purpose Acquisit Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:02AM Form SCHEDULE 13G Apex Treasury Corp Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:01AM Form SCHEDULE 13G Lifezone Metals Ltd Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:01AM Form SCHEDULE 13G Activate Energy Acquisit Filed by: Adage Capital Management, L.P.
Feb 12, 2026 09:00AM Form SCHEDULE 13G Invest Green Acquisition Filed by: Adage Capital Management, L.P.
Jan 28, 2026 09:35AM Form D/A Adage Capital Partners,
Jan 22, 2026 08:00AM CORXEL Announces $287 million Series D1 Financing to Further Advance Its Cardiometabolic Pipeline including Oral Small Molecule GLP-1 Receptor Agonist
Jan 12, 2026 07:45AM Mirador Accelerates Multi-Asset Clinical Pipeline in Immuno-Fibrotic Disease; Closes $250 Million Series B with Premier Investors
Jan 7, 2026 06:30AM Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Dec 16, 2025 08:06AM Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1
Dec 2, 2025 07:00AM Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
Nov 28, 2025 09:20AM Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
Nov 19, 2025 09:08AM Pathway to Cures Invests in SeraGene Therapeutics
Nov 14, 2025 01:15PM Form 13F-NT Adage Capital Management For: Sep 30
Nov 14, 2025 01:14PM Form 13F-HR ADAGE CAPITAL PARTNERS For: Sep 30
Nov 13, 2025 04:05PM Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
Nov 13, 2025 09:17AM Form SCHEDULE 13G iBio, Inc. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:16AM Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:15AM Form SCHEDULE 13G/A Sitio Royalties Corp. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:14AM Form SCHEDULE 13G/A Dynamix Corp Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:11AM Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:11AM Form SCHEDULE 13G Equillium, Inc. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:10AM Form SCHEDULE 13G Milestone Pharmaceutical Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:09AM Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:08AM Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:07AM Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:07AM Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Adage Capital Management, L.P.
Nov 13, 2025 09:06AM Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: Adage Capital Management, L.P.
View More Recent Stories View Older Stories